Company news

AtriCure, Inc. news in 2021

AtriCure, Inc.'s news releases, calls and decks from 2021, newest first.

View company

AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference

December 19, 2021

AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference

November 11, 2021

AtriCure Reports Third Quarter 2021 Financial Results

November 2, 2021

AtriCure to Announce Third Quarter 2021 Financial Results

October 4, 2021

AtriCure to Participate at the Morgan Stanley 19th Annual Global Healthcare Conference

August 30, 2021

AtriCure Reports Second Quarter 2021 Financial Results

August 3, 2021

AtriCure to Participate at the Canaccord 41st Annual Growth Conference

July 29, 2021

AtriCure to Announce Second Quarter 2021 Financial Results

July 6, 2021

AtriCure Names Two New Members to the Board of Directors

June 14, 2021

AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients

April 28, 2021

AtriCure Reports First Quarter 2021 Financial Results

April 26, 2021

AtriCure Names B. Kristine Johnson Board Chair

April 7, 2021

AtriCure to Announce First Quarter 2021 Financial Results

April 5, 2021

AtriCure to Participate at the Oppenheimer 31st Annual Healthcare Conference

March 1, 2021

AtriCure Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

February 22, 2021

AtriCure to Participate at the SVB Leerink 10th Annual Global Healthcare Conference

February 9, 2021

AtriCure to Announce Fourth Quarter and Full Year 2020 Financial Results

February 1, 2021

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020

January 10, 2021

AtriCure Announces Labeling Expansion for Cryo Nerve Block Therapy

January 3, 2021

Calls in 2021

Decks in 2021